Medicine: New insight into old IBD drug could improve treatments
Ithaca, 22 Feb, 2024.- Although it is one of the oldest medications used to treat patients with inflammatory bowel disease (IBD) and an effective treatment for an associated arthritis condition called spondyloarthritis (SpA), sulfasalazine’s mechanism of action has been unclear. Now researchers at the Jill Roberts Center for IBD andContinuar Leyendo



















